Tuberculosis during JAK inhibitor or TNF-α inhibitors therapy: a disproportionality analysis from WHO pharmacovigilance database.
- DOI
- 10.1136/thorax-2025-223332
- Published
- 2026 Sep 9
- Container
- Thorax
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/thorax-2025-223332,
title = {Tuberculosis during JAK inhibitor or TNF-α inhibitors therapy: a disproportionality analysis from WHO pharmacovigilance database.},
author = {Maitre T and Bihan K and Veziris N and Godet C and Parrot A and Djibre M and Lebrun Vignes B and Cadranel J},
year = {2026},
journal = {Thorax},
doi = {10.1136/thorax-2025-223332},
url = {https://doi.org/10.1136/thorax-2025-223332}
}RIS
TY - JOUR TI - Tuberculosis during JAK inhibitor or TNF-α inhibitors therapy: a disproportionality analysis from WHO pharmacovigilance database. AU - Maitre T AU - Bihan K AU - Veziris N AU - Godet C AU - Parrot A AU - Djibre M AU - Lebrun Vignes B AU - Cadranel J PY - 2026 JO - Thorax DO - 10.1136/thorax-2025-223332 UR - https://doi.org/10.1136/thorax-2025-223332 ER -
APA
T, M., K, B., N, V., C, G., A, P., M, D., B, L. V., & J, C. (2026). Tuberculosis during JAK inhibitor or TNF-α inhibitors therapy: a disproportionality analysis from WHO pharmacovigilance database.. Thorax. https://doi.org/10.1136/thorax-2025-223332
Source records
- pubmed · retrieved 2026-09-26T09:32:08.173Z
- europe-pmc · retrieved 2026-09-26T09:32:08.187Z